Exam 4 Heart Failure Part 1 (Bri) Flashcards

1
Q

Heart failure is an emerging worldwide epidemic with more than ____ million pts in the US will be treated for the condition by 2030

A

8 million

slide 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HF is defined as a complex syndrome that results from any structural or functional impairment of ____ or _____.

A

ventricular filling or blood ejection

slide 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HF leads to:

A
  • tissue-hypoperfusion
  • causingfatigue
  • dyspnea
  • weakness
  • edema
  • weight gain

slide 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HF may be caused by structural abnormalities of the ….?

A
  • pericardium
  • myocardium
  • endocardium
  • heart valves
  • or great vessels

slide 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HF with reduced EF (HFrEF, aka ____HF) is classified as HF w/ EF ___

A
  • systolic HF
  • ≤40%

slide 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HF with preserved EF (HFpEF, aka ____ HF) is diagnosed as HF w/ EF____

A
  • diastolic HF
  • ≥50%

slide 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HF symptoms and an EF btw 40-49%

A

Borderline HFpEF

slide 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

____ dysfunction is present in both HFrEF andHFpEF

A

Diastolic

slide 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are distinguishing features between HFrEF and HFpEF?

A
  • LV dilation patterns
  • remodeling
  • also have different responses to medicaltreatment

slide 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

____ remains a useful tool, as it is easily measured onechocardiogramand serves asthe main marker for determining HF risk factors, treatment, and outcomes

A

Ejection fraction

slide 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

̴1/2 HF pts have normal (____%) ejection fraction

A
  • > 50%

slide 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The proportion of pts with HFpEF is increasing d/t its relationship w/conditions such as :

A
  • HTN
  • DM
  • A-fib
  • obesity
  • metabolic syndrome
  • COPD
  • renal insufficiency
  • anemia

slide 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pts with HFrEF are more likely to have modifiable risk factors (smoking, hyperlipidemia) as well as a higher incidence of :

A
  • myocardial ischemia & infarction
  • previous coronary intervention
  • CABG
  • PVD

slide 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • ____% HF cases are HFpEF
  • ____% are HFrEF
  • ____% are borderline HFpEF (EF 40-49%)
A
  • 52% HF cases are HFpEF
  • 33% are HFrEF
  • 16% are borderline HFpEF (EF 40-49%)

slide 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • ____ are more likely to be affected by HFpEF
  • ____ more likely to be affected by HFrEF
A
  • Women are more likely to be affected by HFpEF
  • Men more likely to be affected by HFrEF

slide 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LV diastolic dysfunction (LVDD) is the primary determinant of ____, whereas contractile dysfunctionis the primary determinant for ____.

A
  • HFpEF
  • HFrEF

slide 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

The LV’s ability to fill is determined by:

A
  • pulmonary venous blood flow
  • LA function
  • mitral valve dynamics
  • pericardial restraint
  • the active & passive elastic properties of LV

slide 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

LV diastolic function is normal when these factors combine to provide a LVEDV (preload) that provides sufficient ____ for cellular metabolism without elevating ____ and ____.

A
  • cardiac output
  • pulmonary venous pressures and LA pressures

slide 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

LVDD

The majority ofLVDD measurements depend on:

A
  • HR
  • loading conditions
  • andmyocardial contractility

slide 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

In HFpEF, higher LV filling pressures are required to achieve normal ____

A

end-diastole volume

slide 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

A steeper rise of the end-diastolic pressure-volume curve is indicative of ____ LV relaxation and ____ myocardial stiffness. This leads to:

A
  • delayed
  • increased

Leads to:
* reduced LV compliance and precipitates LA hypertension
* LA systolic &diastolic dysfunction
* pulmonary venous congestion
* exercise intolerance

slide 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q
  • what does the left LV pressure volume loop show?
  • what does the right LV pressure volume loop show?
A
  • Left: decreased contractility is indicated by a decrease in the slope of the end-systolic pressure-volume relation(HFrEF)
  • Right: decreased in LV compliance is indicated by an increase in the end-diastolic pressure-volume relation slope (HFpEF)
  • These diagrams emphasize that heart failure may result from LV systolic or diastolic dysfunction independently

slide 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what are common causes of left ventricular diastolic dysfunction?

A

slide 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Delays in relaxation are a form of “____” c/b failure of the actin-myosin disassociation, which occurs due to ____ or ____.

A
  • active stiffening
  • occurs d/t: inadequate perfusion or dysfunctional intracellular Ca++ homeostasis

slide 9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

LV relaxation d/o afterload, which is typically elevated in ____ pts

A

hypertensive

slide 9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

____ exacerbates the failure of LV relaxation

A

Tachycardia

slide 9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q
  • Profound exercise intolerance is seen w/HFpEF despite having only a modestly depressed ____
  • In addition, prolonged compression of the coronary arteries restricts diastolic coronary blood flow, which contributes to ____ and a further reduction in exercise tolerance
A
  • LV systolic function
  • subendocardial ischemia

slide 9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Most common symptoms of HF?

A
  • fatigue
  • tachypnea
  • dyspnea
  • paroxysmal nocturnal dyspnea
  • orthopnea
  • S3 gallop
  • JVD
  • peripheral edema
  • exercise intolerance
  • reduced tissue perfusion

slide 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what symptoms are more common with HFpEF?

A
  • paroxysmal nocturnal dyspnea
  • pulmonary edema
  • dependent edema

slide 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what sypmtom is more common with HFrEF

A

S3 gallop

slide 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

When EF is reduced, the presence of HF symptoms establishes the diagnosis of ____(following standard guidelines)

A

HFrEF

slide 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

In contrast to ____ , the initial diagnosis of____is often more difficult,especially when the pt has little/no symptoms at rest

A
  • HFrEF
  • HFpEF

slide 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Cardiac catheterization defines ____ and ____ usingpressure-volume analysis or provocative testing (s/a exercise & rapid IV volumeexpansion)

A

elevated LV systolic and diastolic stiffness

slide 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Direct measurement of RV filling pressures offers further information about the severity of____

A

HFpEF

slide 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Mean pulmonary capillary wedge pressure >____mmHg at rest or ____mmHg duringexercise provides strong evidence ofHFpEFand is a predictor of mortality

A
  • > 15 mmhg
  • 25 mmhg

slide 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

CXR may detect what?

A
  • pulmonary dz
  • cardiomegaly
  • pulmonary venous congestion
  • interstitial or alveolar pulmonary edema

slide 13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

CXR

An early radiographic sign of LV failure & pulmonary venous HTN is distention of ?

A

the pulmonary veins in the upper lobes of the lungs

slide 13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Perivascular edema appears as ?

A

a hilar or perihilar haze with ill-defined margins

slide 13

39
Q

____, produce a honeycomb pattern, reflect interlobular edema & may be present in HF

A

Kerley lines

slide 13/14

40
Q

____ produces homogeneous densities in the lung fields, typically in a butterfly pattern

A

Alveolar edema

slide 13

41
Q

what may be present in CXR with HF?

A

Pleural effusion and pericardial effusion

slide 13

42
Q

Radiographic evidence of pulmonary edema may lag behind the clinical evidence of pulmonary edema by up to ____ hours

A

12 hours

slide 13

43
Q

echocardiogram

The ACC/AHA diagnostic criteria d/o 3 factors:

A
  • HF sx
  • EF >50%
  • evidence of LVDD
  • This approach is useful for pts with clear symptomatology, but may be too simplistic for subclinical HFpEF

slide 15

44
Q

The ESC criteria is ____ specific and incorporates several echocardiographic indexes based on ____ measurements

A
  • more
  • 2-dimensional

slide 15

45
Q

ESC guidelines rely entirely on resting echocardiogram; and are limited because?

A

they do not incorporate provocative testing

slide 15

46
Q

ACC/AHA criteria vs ESC crietria of HF?

A

slide 15

47
Q
  • Electrocardiogram: EKG abnormalities are common in HF pts and are typically related to?
  • EKG alone has a ____ predictive value for diagnosis or risk-prediction of heart failure
A

related to
* underlying pathology s/a LVH
* previous MI
* arrhythmias
* conduction abnormalities

EKG alone has a LOW predcitvie value

slide 16

48
Q

what labs can be used to diagnose HF?

A
  • Brain natriuretic peptide (BNP)&N-terminal pro-BNP
  • Troponins
  • C-reactive protein(CRP)
  • growth differentiation factor-15(GDF15)

slide 17

49
Q

Brain natriuretic peptide (BNP)&N-terminal pro-BNPareimportant ____.

A

biomarkers

slide 17

50
Q
  • Natriuretic peptide concentrations are related to LV end-diastolic wall stress,which is higher in HFrEFd/t LV dilation & ____ remodeling
  • In contrast, HFpEF is assoicatedw/ ____ hypertrophy, relatively normal LV chamber size, and lower LV end-diastolic wallstress, allowing for lower BNP or NT-proBNPlevels
A
  • eccentric
  • concentric

slide 17

`

51
Q

____are systemically released d/t myocardial damage and serve as ameasure of risk prediction

A

Troponins

slide 17

52
Q

BothC-reactive protein(CRP) andgrowth differentiation factor-15(GDF15)represent what?

A

the inflammatory component of HF

slide 17

53
Q

The New York Heart Association (NYHA) and the ACC/AHA created classification systems for HF. The NYHA system focuses primarily on ____ whereas the ACC/AHA focus on ____.

A
  • NYHA: the degree of physical limitation
  • ACC/AHA: the presence & severity of HF

slide 18

54
Q

Classification of HF

  • Since progression of HF is linked to reduced 5-year survival, it is important to note that these stages are ____
  • Pts are oftenclassified using a combination of ____?
A
  • progressive
  • both scoring systems(NYHA and ACC/AHA)

slide 18

55
Q

Chronic HF treatment

  • Survival of pts w/ ____ has improved during the past three decades, but the mortality in those with ____ remains unchanged
  • Medication treatments are ineffective for____, although benefit is seen in pts with ____
A
  • HFrEF | HFpEF
  • HFpEF | HFrEF

slide 19

56
Q
  • HFpEF tx:
  • HFrEF tx:
A
  • HFpEF tx: Mitigation of sx’s, treat associated conditions, exercise, weight loss
  • HFrEF tx: ΒB’s and ACE-inhibitors

slide 19

57
Q

what is the treatment algorithm for HFpEF?

A

slide 20

58
Q

CHF Tx (Diuretics)

  • ____diuretics are recommended per ACC & ESC guidelines as they reduce LV filling pressures, decrease pulmonary venous congestion, and improve HF sx
  • ____ diuretics may be useful in pts with poorly controlled HTN to prevent the onset of HFpEF
A
  • Loop diuretics
  • thiazide diuretics

slide 21

59
Q
  • ____ strongly recommended for HFrEF.
  • this medication is not clearly establised for HFpEF but are prescribed for indications such as?
A
  • beta blockers
  • other indications: HTN, MI, HR control w/Afib

slide 21

60
Q

what is the mainstay treatment for HFrEF?

A
  • ACE-I and ARBs
  • however, studies do not show benefit in HFpEF unless used for treatment of HTN

slide 22

61
Q

what lifestyle changes cna help treat HF?

A
  • Aerobic fitness reduces symptoms, and increases quality of life in HF pts
  • Weight loss significantly reduces major risk factors for HF, including HTN & DM
  • Salt-restricted Dietary Approaches to Stop Hypertension (DASH) diet improves LV diastolic function, decreases arterial stiffness, and facilitates LV-arterial coupling in pts w/ HFpEF
  • Control of HTN and blood glucose are also important

slide 22

62
Q

The goal of surgical treatment for chronic HF is to prevent ventricular remodeling and retain the natural geometry of the heart. What are surgical treatments mentioned in class?

A
  • revascularization
  • Cardiac resynchronization therapy (CRT):
  • Implantable hemodynamic monitoring
  • Implantable cardioverting-defibrillators (ICDs)
  • LV assist devices

slide 23-25

63
Q
  • ____ via CABG or PCI can reverse LV dysfunction following MI
  • Successful early intervention may prevent ____
  • ____ has been shown to reduce 10-year mortality by 7%
A
  • Coronary revascularization
  • permanent EF reductions
  • CABG

slide 23

64
Q

Aka “biventricular pacing,” is a tx for HF w/a ventricular conduction delay (prolonged QRS)

A

Cardiac resynchronization therapy (CRT)

slide 23

65
Q

How is CRT performed?

A
  • placement of a dual-chamber cardiac pacemaker (w/RA & RV leads), an additional lead is introduced through the coronary sinus and advanced until it reaches the lateral wall of the LV
  • This stimulates the heart to contract more synchronously and efficiently and improve COP

slide 23

66
Q

CRT is recommended for pts with NYHA class ____ or ____ w/ EF < ____% and a QRS duration ____ms

A
  • III or IV
  • EF < 5%
  • QRS duration 120-150 ms

slide 23

67
Q

CRT outcomes:

A
  • fewer HF sx
  • better exercise tolerance
  • improved ventricular function
  • less hospitalizations
  • decreased mortality

slide 23

68
Q

risks of CRT include

A
  • infection
  • misplacement
  • device failure

slide 23

69
Q

____ allows remote observation of intracardiac pressures to guide tx and prevent decompensation

A

plantable hemodynamic monitoring

slide 24

70
Q

The ____ system allows for management of LV filling pressures based on daily measurement of noninvasive PAP obtained at home by the pt and then uploaded to their physician

A

CardioMEMS Heart Failure

slide 24

71
Q
  • ____ is used for prevention of sudden death in pts with advanced heart failure
  • ̴ ____% HF deaths are d/t sudden cardiac dysrhythmias
A
  • Implantable cardioverting-defibrillators (ICDs)
  • ~50%

slide 24

72
Q

Pts in the terminal stages of HF may benefit from mechanical circulatory support (MCS) by a ____

A

ventricular assist device (VAD)(LV assist device)

slide 25

73
Q
  • Studies show an increased survival and improved quality of life in HF pts treated w/____ compared to medical therapy alone
  • These mechanical pumps can take over ____ or ____ function of the damaged ventricle and facilitate restoration of normal hemodynamics and perfusion
A
  • VADs
  • partial or total

slide 25

74
Q

LVAD is used for?

A
  • temporary ventricular assistance while heart is recovering its function
  • Pts awaiting cardiac transplant
  • Pts are on inotropes or balloon pump (IABP) with potentially reversible medical conditions
  • Pts with advanced HF who aren’t transplant candidates

slide 25

75
Q

____ is classified as long-standing HF disease

A

Chronic heart failure

slide 27

76
Q
  • ____ has rapid onset, often presenting w/life-threatening conditions
  • Pts may require hospitalization, txis aimed at ____ and ____
A
  • Acute heart failure
  • tx is aimed at: decreasing volume & stabilizing hemodynamics

slide 27

77
Q

The term “acute heart failure” applies to

A
  • pts who present with worsening preexisting HF (acute decompensated heart failure [ADHF])
  • those who present for the first time with HF (de novo acute heart failure [de novo AHF])

slide 27

78
Q

acute decompensated HF (ADHF) symptoms include:

A
  • fluid retention
  • weight gain
  • dyspnea

as the result of decompensation due to inadequate compensation

slide 27

79
Q

____ is characterized by a sudden increase in intracardiac filling pressuresor acute myocardial dysfunction,leading to decreased peripheral perfusion and pulmonary edema

A

De novo AHF

slide 28

80
Q

Cardiac ischemia c/b a coronary occlusion is the leading cause of de novo HF; therefore,management is focused on:

A
  • stabilizing hemodynamics
  • restoring myocardial perfusion
  • improving myocardial contractility

slide 28

81
Q

Less common nonischemic causes of de novo HF include:

A
  • viral
  • drug-induced (toxic)
  • peripartum cardiomyopathies

slide 28

82
Q

de novo HF may lead to long-term cardiac dysfunction; however, management of theunderlying causemay allow for ____

A

complete restoration

slide 28

83
Q

As pts present either in ____ or ____ the CRNA may be faced with stabilizing these pts for urgent/emergent surgery

A

ADHF or de novo HF

slide 29

84
Q

The hemodynamic profile of acute HF includes:

A
  • low cardiac output
  • high ventricular filling pressures
  • HTN or HoTN

slide 29

85
Q

what is the 1st line of treatment for acute HF? when should the be given and why?

A
  • diuretics
  • give immediately in pts with FVO
  • to migate sx and decrease mortality

slide 29

86
Q

AHF pt with ____ or ____ may first require hemodynamic support prior to diuretic therapy

A

HoTN or cardiogenic shock

slide 29

87
Q

what diuretics should be used for AHF?

A
  • Furosemide
  • Bumetanide
  • Torsemide
  • given as bolus or continuous infusions

slide 29

88
Q

diuretics reduce intravascular volume which leads to ?

A

Reducing in intravascular volume leads to decreased central venous and pulmonary capillary wedge pressures (PCWP), reducing pulmonary congestion

slide 29

89
Q

____ areproven to correct elevated filling pressures and reduceafterload; however, evidence is lacking on their efficacy inAHF

A

Vasodilators

slide 30

90
Q

careful consideration of vasodilators is critical and b/o the underlying ____

A

hemodynamics

slide 30

91
Q

____ is effective to rapidly decrease afterload, whereas ____ is commonly used as an adjunct to diuretic therapy

A
  • SNP
  • NTG

slide 30

92
Q

routine use of is not shown toimprove outcomes in AHF

A

vasodilators

slide 30

93
Q

Vasopressin receptor antagonists: such as ____ have emerged as potential adjunct therapy in AHF to reduce ….?

A
  • Tolvaptan
  • to reduce the arterial constriction, hyponatremia, and the volume overload associated with AHF

slide 30

94
Q

medications used for acute HF:

A
  • diuretics
  • vasodilators
  • vasopressin receptor antagonist
  • Positie inotropes (catecholamines and PDE-i)
  • exogenous BNP

slide 29-33